{"id":454620,"date":"2021-03-10T08:03:13","date_gmt":"2021-03-10T13:03:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=454620"},"modified":"2021-03-10T08:03:13","modified_gmt":"2021-03-10T13:03:13","slug":"cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/","title":{"rendered":"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\" style=\"font-weight:normal\"><b>Cortexyme to Present at the Oppenheimer 31<sup>st<\/sup> Annual Healthcare Conference on March 16, 2021<\/b><\/p>\n<p class=\"bwalignc\"><i>&#8212; Presentation to be webcast on Cortexyme\u2019s website &#8212;<\/i><\/p>\n<p>SOUTH SAN FRANCISCO, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer\u2019s and other degenerative diseases, today announced Chris Lowe, the company\u2019s chief operating officer and chief financial officer, will present at the Oppenheimer 31<sup>st<\/sup> Annual Healthcare Conference, a virtual event, on Tuesday, March 16, 2021, at 4:00 p.m. EDT \/ 1:00 p.m. PDT.\n<\/p>\n<p>\nA live webcast of the presentation will be accessible on the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.cortexyme.com%2Fnews-and-events%2Finvestor-calendar&amp;esheet=52393633&amp;newsitemid=20210310005461&amp;lan=en-US&amp;anchor=Investor+Calendar&amp;index=1&amp;md5=169ab4ee6d7e9fe17ac44870020095cf\">Investor Calendar<\/a> page under the News &amp; Events heading of the Cortexyme investor site (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fir.cortexyme.com&amp;esheet=52393633&amp;newsitemid=20210310005461&amp;lan=en-US&amp;anchor=ir.cortexyme.com&amp;index=2&amp;md5=ba91937424b095c4fb28e7de3a4da9fe\">ir.cortexyme.com<\/a>). The webcast will be archived at that location for 90 days.\n<\/p>\n<p><b>About Cortexyme<\/b><\/p>\n<p>\nCortexyme, Inc. (Nasdaq: CRTX) is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer\u2019s and other degenerative diseases. Based upon the evidence generated to date, Cortexyme is currently advancing its lead therapeutic candidate, atuzaginstat (COR388), in the GAIN Trial, an ongoing Phase 2\/3 clinical trial in patients with mild to moderate Alzheimer\u2019s disease. Cortexyme is targeting a specific, infectious pathogen found in the brain and other organs and tied to degeneration and inflammation in humans and animal models. To learn more about Cortexyme, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cortexyme.com&amp;esheet=52393633&amp;newsitemid=20210310005461&amp;lan=en-US&amp;anchor=www.cortexyme.com&amp;index=3&amp;md5=d252d26bb353289bcb75e3c0aafdf504\">www.cortexyme.com<\/a> or follow @Cortexyme on Twitter.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210310005461\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210310005461\/en\/<\/a><\/span><\/p>\n<p><b>Corporate Contact:<br \/>\n<\/b><br \/>Chris Lowe<br \/>\n<br \/>Chief Operating Officer &amp;<br \/>\n<br \/>Chief Financial Officer<br \/>\n<br \/>Cortexyme, Inc.<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:clowe@cortexyme.com\">clowe@cortexyme.com<\/a><\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>Corey Davis, Ph.D.<br \/>\n<br \/>LifeSci Advisors<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:cdavis@lifesciadvisors.com\">cdavis@lifesciadvisors.com<br \/>\n<\/a><br \/>212-915-2577\n<\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/>Hal Mackins<br \/>\n<br \/>For Cortexyme, Inc.<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:hal@torchcomllc.com\">hal@torchcomllc.com<br \/>\n<\/a><br \/>(415) 994-0040\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Other Health Research General Health Pharmaceutical Mental Health Medical Devices Genetics Clinical Trials Science Biotechnology FDA Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210310005461\/en\/632816\/3\/Cortexyme_logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 &#8212; Presentation to be webcast on Cortexyme\u2019s website &#8212; SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211; Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer\u2019s and other degenerative diseases, today announced Chris Lowe, the company\u2019s chief operating officer and chief financial officer, will present at the Oppenheimer 31st Annual Healthcare Conference, a virtual event, on Tuesday, March 16, 2021, at 4:00 p.m. EDT \/ 1:00 p.m. PDT. A live webcast of the presentation will be accessible on the Investor Calendar page under the News &amp; Events heading of the Cortexyme investor site (ir.cortexyme.com). The webcast will be archived at that location for 90 days. About Cortexyme &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-454620","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 &#8212; Presentation to be webcast on Cortexyme\u2019s website &#8212; SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211; Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer\u2019s and other degenerative diseases, today announced Chris Lowe, the company\u2019s chief operating officer and chief financial officer, will present at the Oppenheimer 31st Annual Healthcare Conference, a virtual event, on Tuesday, March 16, 2021, at 4:00 p.m. EDT \/ 1:00 p.m. PDT. A live webcast of the presentation will be accessible on the Investor Calendar page under the News &amp; Events heading of the Cortexyme investor site (ir.cortexyme.com). The webcast will be archived at that location for 90 days. About Cortexyme &hellip; Continue reading &quot;Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-10T13:03:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021\",\"datePublished\":\"2021-03-10T13:03:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/\"},\"wordCount\":317,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/\",\"name\":\"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-03-10T13:03:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/","og_locale":"en_US","og_type":"article","og_title":"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 - Market Newsdesk","og_description":"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 &#8212; Presentation to be webcast on Cortexyme\u2019s website &#8212; SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211; Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer\u2019s and other degenerative diseases, today announced Chris Lowe, the company\u2019s chief operating officer and chief financial officer, will present at the Oppenheimer 31st Annual Healthcare Conference, a virtual event, on Tuesday, March 16, 2021, at 4:00 p.m. EDT \/ 1:00 p.m. PDT. A live webcast of the presentation will be accessible on the Investor Calendar page under the News &amp; Events heading of the Cortexyme investor site (ir.cortexyme.com). The webcast will be archived at that location for 90 days. About Cortexyme &hellip; Continue reading \"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-10T13:03:13+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021","datePublished":"2021-03-10T13:03:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/"},"wordCount":317,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/","name":"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-03-10T13:03:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210310005461r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-on-march-16-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=454620"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454620\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=454620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=454620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=454620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}